U.S. - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMedicaments Containing Hormones Price in the United States - 2023
Contents:
- Medicaments Containing Hormones Price in the United States (FOB) - 2022
- Medicaments Containing Hormones Price in the United States (CIF) - 2022
- Medicaments Containing Hormones Exports in the United States
- Medicaments Containing Hormones Imports in the United States
Medicaments Containing Hormones Price in the United States (FOB) - 2022
In 2022, the average medicaments containing hormones export price amounted to $67,112 per ton, increasing by 51% against the previous year. Overall, the export price posted a strong increase. The most prominent rate of growth was recorded in 2020 an increase of 156% against the previous year. Over the period under review, the average export prices reached the peak figure in 2022 and is likely to see steady growth in years to come.
There were significant differences in the average prices for the major foreign markets. In 2022, amid the top suppliers, the country with the highest price was Ireland ($1,939,999 per ton), while the average price for exports to Canada ($3,476 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Ireland (+52.0%), while the prices for the other major destinations experienced more modest paces of growth.
Medicaments Containing Hormones Price in the United States (CIF) - 2022
The average medicaments containing hormones import price stood at $65,423 per ton in 2022, declining by -12.4% against the previous year. Over the period under review, the import price continues to indicate a drastic downturn. The pace of growth was the most pronounced in 2018 when the average import price increased by 59% against the previous year. Over the period under review, average import prices attained the maximum at $366,956 per ton in 2013; however, from 2014 to 2022, import prices stood at a somewhat lower figure.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Belgium ($224,854 per ton), while the price for Denmark ($51,210 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Portugal (-0.3%), while the prices for the other major suppliers experienced a decline.
Medicaments Containing Hormones Exports in the United States
In 2022, exports of medicaments containing hormones but not antibiotics from the United States declined markedly to 4K tons, shrinking by -35.4% against 2021. Over the period under review, exports faced a deep reduction. The pace of growth was the most pronounced in 2021 when exports increased by 132%.
In value terms, medicaments containing hormones exports reduced modestly to $270M in 2022. In general, total exports indicated a remarkable increase from 2019 to 2022: its value increased at an average annual rate of +15.3% over the last three years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by +53.2% against 2019 indices. The growth pace was the most rapid in 2021 when exports increased by 54%. As a result, the exports attained the peak of $276M, and then reduced in the following year.
| Export of Medicaments Containing Hormones in the United States (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Switzerland | 106 | 110 | 114 | 140 | 9.7% |
| Denmark | 3.0 | 5.8 | 30.0 | 43.7 | 144.2% |
| Ireland | 34.9 | 39.0 | 77.1 | 40.5 | 5.1% |
| Japan | 0.4 | 4.9 | 22.3 | 9.6 | 188.4% |
| Canada | 4.1 | 1.6 | 14.6 | 4.8 | 5.4% |
| Others | 27.5 | 18.9 | 18.5 | 31.5 | 4.6% |
| Total | 176 | 180 | 276 | 270 | 15.3% |
Top Export Markets for Medicaments Containing Hormones from the United States in 2022:
- Canada (1388.3 tons)
- Switzerland (1352.9 tons)
- Denmark (957.9 tons)
- Japan (67.9 tons)
- Ireland (20.9 tons)
Medicaments Containing Hormones Imports in the United States
For the fourth year in a row, the United States recorded growth in purchases abroad of medicaments containing hormones but not antibiotics, which increased by 144% to 1.9K tons in 2022. In general, imports saw significant growth. The most prominent rate of growth was recorded in 2021 with an increase of 304% against the previous year. Over the period under review, imports reached the maximum in 2022 and are expected to retain growth in the near future.
In value terms, medicaments containing hormones imports surged to $123M in 2022. Over the period under review, imports enjoyed a significant increase. The pace of growth appeared the most rapid in 2021 when imports increased by 131% against the previous year. Over the period under review, imports reached the maximum in 2022 and are expected to retain growth in the near future.
| Import of Medicaments Containing Hormones in the United States (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Denmark | N/A | N/A | 34.8 | 86.4 | 148.3% |
| India | 0.7 | 3.8 | 5.0 | 13.8 | 170.1% |
| Belgium | 4.0 | 2.3 | 14.6 | 13.4 | 49.6% |
| Japan | 2.4 | 1.3 | 1.8 | 3.3 | 11.2% |
| Jordan | 3.4 | 3.4 | N/A | N/A | 0.0% |
| Portugal | 14.1 | 12.4 | N/A | N/A | -12.1% |
| Others | 2.2 | 1.6 | 1.2 | 5.7 | 37.3% |
| Total | 26.8 | 24.9 | 57.4 | 123 | 66.2% |
Top Suppliers of Medicaments Containing Hormones to the United States in 2022:
- Denmark (1686.7 tons)
- India (65.0 tons)
- Belgium (59.8 tons)
- Japan (38.1 tons)
This report provides an in-depth analysis of the medicaments containing hormones market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201250 - Medicaments containing hormones but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale (excluding insulin)
Country coverage:
- United States
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
330
This report provides an in-depth analysis of the medicaments containing hormones market in the U.S..
380
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
386
This report provides an in-depth analysis of the medicaments containing penicillin market in the U.S..
273
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in the U.S..
209
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in the U.S..
183
This report provides an in-depth analysis of the market for medicaments of other antibiotics in the U.S..
475
This report provides an in-depth analysis of the global medicaments containing hormones market.
472
This report provides an in-depth analysis of the global medicaments containing insulin market.
562
This report provides an in-depth analysis of the global medicaments containing penicillin market.
301
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
71
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
71
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
